MAP 2.94% 17.5¢ microba life sciences limited

Ann: Details of Q3 FY23 Quarterly Report, Appendix 4C & Webinar, page-2

  1. 292 Posts.
    lightbulb Created with Sketch. 105
    the selling is relentless you would have to think the quarterly has no sales growth from what the share price is saying. Some one wants out and has continued too offload. Delays on these results aren't a good look especially when they said ind the next 10 days. No buyers out there
 
watchlist Created with Sketch. Add MAP (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.